Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Peginterferon alfa-2a submitted for approval as hepatitis therapy in Japan

Jan. 13, 2003

Altana researchers investigate novel anti-H. pylori agents

Jan. 13, 2003

Pharmacia selects backup compound to LTA4 hydrolase inhibitor SC-57461A

Jan. 9, 2003

Experimental acute pancreatitis in mice improved by adenosine uptake inhibitor KF-24345

Jan. 9, 2003

Vertex to lead development of VX-950 in restructured agreement with Lilly

Jan. 8, 2003

Potent, nonpeptide CCK1 receptor antagonist developed by Italian scientists

Jan. 8, 2003

Modified antisense oligonucleotides targeting ICAM-1 and VCAM-1 show potential in IBD

Jan. 7, 2003

Progenics commences phase III program for methylnaltrexone

Dec. 30, 2002

Piperidine-based motilin agonists described by Solvay

Dec. 27, 2002

Efficacy of alicaforsen reported in patients with active Crohn's disease

Dec. 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...